【Adimmune Corporation】Q1 2026 EPS -NT$0.44
NQ Score
0/100
N1 Content Completeness
2
AI Summary (NQ-processed)
Adimmune Corporation, a company in the biotechnology and medical care industry, announced its financial results for the first quarter of 2026, reporting a basic earnings per share of -NT$0.44, operating revenue of NT$82 million, and a net loss of NT$200 million.